A first-of-its-kind treatment from GenSight Biologics partially restored a blind patient's vision by combining gene therapy and specialized goggles.
A first-of-its-kind treatment from GenSight Biologics partially restored a blind patient's vision by combining gene therapy and specialized goggles.